Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III). - Wikidata - awgldk - TriplyDB

Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).

Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).

http://www.wikidata.org/entity/Q37027913

about

Development of a measure of therapy provision for spasticity management in the paretic lower limb - the Leg Therapy recording Schedule (LegTS).

P2860

Q39031742-FD446FF1-CF22-4572-A304-530E086E2577

P2860

Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).

http://www.wikidata.org/entity/Q37027913

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Impact of integrated upper lim ...... dinal cohort study (ULIS-III).

@en

Impact of integrated upper lim ...... dinal cohort study (ULIS-III).

@nl

type

label

Impact of integrated upper lim ...... dinal cohort study (ULIS-III).

@en

Impact of integrated upper lim ...... dinal cohort study (ULIS-III).

@nl

prefLabel

Impact of integrated upper lim ...... dinal cohort study (ULIS-III).

@en

Impact of integrated upper lim ...... dinal cohort study (ULIS-III).

@nl

P1433

Q37027913-09A9AA6C-6F7C-4816-B0D6-C1FD9A021475

P1476

Q37027913-1609A037-66E7-4DAA-A2ED-107B7BF3E6DF

P2093

Q37027913-02E432FD-7E7F-457B-B7C7-56C7370C1BFD

Q37027913-04D1570C-7A02-40BB-BE3C-B6160C0F37A7

Q37027913-B5BE6504-6F63-4D42-A9BD-C336D28D9625

Q37027913-BF546833-79BF-42BD-B185-00769B9DEA27

P2860

Q37027913-063DD577-5D2D-415B-BE84-3BBB83BDA27C

Q37027913-07DDC312-EEC9-4918-B503-C7AF20AD0ACC

Q37027913-0F051479-FFF3-41D5-9ABF-F470A8CED914

Q37027913-15B2DCE3-A894-4E77-9C70-F1191634026C

Q37027913-2484F954-0190-40BA-80FD-824E85D2567F

Q37027913-2C04737A-B108-4CFE-A952-F80F81F62D79

Q37027913-2C4CA67F-6463-4F32-A361-E61A3F5B14F0

Q37027913-390A34ED-8399-4271-A892-027BBCB5F231

Q37027913-4195F329-9FEE-495B-AA34-9DF414EC1483

Q37027913-4A726040-985B-4CFB-BC1F-FAED64C5A2E0

P304

Q37027913-C512899B-F1ED-4AE0-8F5F-AB1B840AA910

P31

Q37027913-A44DD5CC-8C0F-4CCA-A683-63F8B74BD13F

P356

Q37027913-9E421ED6-199B-4BCA-BD79-A8D374136A5A

P433

Q37027913-AE4E6BF7-16BD-4DFA-8B18-6526533139DA

P478

Q37027913-D8F1FFC0-B96A-4662-943C-F317448B07F0

P50

Q37027913-54C1E7BD-A510-49DD-9847-0B517F1AC904

Q37027913-B87B72CE-649C-4B7D-9B4B-E43D5DE9BB36

P577

Q37027913-BAAF1215-E02E-473A-B95B-10D08886B0E5

P698

Q37027913-54046780-5CB3-4453-82A0-345F2D59F885

P932

Q37027913-1D169E7E-322F-4AFE-85AC-8F1A2E01321C

P356

BMJOPEN-2016-011157

P1433

P1476

Impact of integrated upper lim ...... udinal cohort study (ULIS-III)

@en

P2093

Jovita Balcaitiene

http://www.w3.org/2001/XMLSchema#string

Klemens Fheodoroff

http://www.w3.org/2001/XMLSchema#string

Lynne Turner-Stokes

http://www.w3.org/2001/XMLSchema#string

Pascal Maisonobe

http://www.w3.org/2001/XMLSchema#string

P2860

Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice

Pathophysiology of spasticity.

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

The International Classification of Functioning, Disability and Health: a new tool for understanding disability and health.

Should patients participate in clinical decision making? An optimised balance block design controlled study of goal setting in a rehabilitation unit.

The Neurological Impairment Scale: reliability and validity as a predictor of functional outcome in neurorehabilitation.

Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management.

Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.

Common goal areas in the treatment of upper limb spasticity: a multicentre analysis.

The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey.

P304

e011157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJOPEN-2016-011157

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Stephen Ashford

P577

2016-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27315835

http://www.w3.org/2001/XMLSchema#string

P932

4916608

http://www.w3.org/2001/XMLSchema#string